Technical Analysis for CMTA - Clementia Pharmaceuticals Inc.

Grade Last Price % Change Price Change
grade C 11.14 2.25% 0.25
CMTA closed up 2.25 percent on Thursday, September 20, 2018, on 35 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical CMTA trend table...

Date Alert Name Type % Chg
Sep 20 Spinning Top Other 0.00%
Sep 20 Inside Day Range Contraction 0.00%
Sep 20 Up 3 Days in a Row Strength 0.00%
Sep 20 Up 4 Days in a Row Strength 0.00%
Sep 20 Up 5 Days in a Row Strength 0.00%
Sep 19 MACD Bullish Centerline Cross Bullish 2.25%
Sep 19 New Uptrend Bullish 2.25%
Sep 19 Up 3 Days in a Row Strength 2.25%
Sep 19 Up 4 Days in a Row Strength 2.25%
Sep 19 Up 5 Days in a Row Strength 2.25%

Older signals for CMTA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Clementia Pharmaceuticals Inc. is a clinical stage biopharmaceutical company. The Company is engaged in developing disease-modifying treatments for patients suffering from debilitating bone and other diseases with high unmet medical need. Its lead product candidate, palovarotene, is an oral small molecule that binds and activates retinoic acid receptor gamma (an RARg agonist), and has activity in preventing abnormal new bone formation as well as scar tissue formation (or fibrosis) in a variety of tissues in animal models. It is developing palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva (FOP) and Multiple Osteochondroma (MO). Its programs focus on diseases involving tissue transformation via retinoic acid receptors (RARs). The Company also has an eye drop formulation of palovarotene that can potently increase tear production and decrease corneal damage.
Is CMTA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 20.15
52 Week Low 8.1
Average Volume 80,907
200-Day Moving Average 14.7126
50-Day Moving Average 10.1279
20-Day Moving Average 10.1253
10-Day Moving Average 10.2035
Average True Range 0.8006
ADX 27.1
+DI 27.8768
-DI 11.5126
Chandelier Exit (Long, 3 ATRs ) 10.0182
Chandelier Exit (Short, 3 ATRs ) 11.4818
Upper Bollinger Band 11.3673
Lower Bollinger Band 8.8833
Percent B (%b) 0.91
BandWidth 24.532606
MACD Line 0.1321
MACD Signal Line -0.0078
MACD Histogram 0.1399
Fundamentals Value
Market Cap 340.07 Million
Num Shares 30.5 Million
EPS -472.48
Price-to-Earnings (P/E) Ratio -0.02
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.79
Resistance 3 (R3) 11.77 11.54 11.68
Resistance 2 (R2) 11.54 11.38 11.55 11.64
Resistance 1 (R1) 11.34 11.27 11.44 11.36 11.61
Pivot Point 11.11 11.11 11.16 11.12 11.11
Support 1 (S1) 10.91 10.95 11.01 10.93 10.67
Support 2 (S2) 10.68 10.84 10.69 10.64
Support 3 (S3) 10.48 10.68 10.60
Support 4 (S4) 10.50